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Michael Wininger,1 Carlo Colantuoni,1,2,4 Daniel R. Weinberger,1,2 Joel E. Kleinman,1,5
and Barbara K. Lipska1,5,*
The human prefrontal cortex (PFC), a mastermind of the brain, is one of the last brain regions to mature. To investigate the role of epige-
netics in the development of PFC, we examined DNAmethylation in ~14,500 genes at ~27,000 CpG loci focused on 50 promoter regions
in 108 subjects range in age from fetal to elderly. DNA methylation in the PFC shows unique temporal patterns across life. The fastest
changes occur during the prenatal period, slow downmarkedly after birth and continue to slow further with aging. At the genome level,
the transition from fetal to postnatal life is typified by a reversal of direction, from demethylation prenatally to increased methylation
postnatally. DNA methylation is strongly associated with genotypic variants and correlates with expression of a subset of genes,
including genes involved in brain development and in de novo DNAmethylation. Our results indicate that promoter DNAmethylation
in the human PFC is a highly dynamic process modified by genetic variance and regulating gene transcription. Additional discovery is
made possible with a stand-alone application, BrainCloudMethyl.Introduction
The human prefrontal cortex (PFC) plays a critical role in
complex cognitive behaviors, personality, decision
making, and orchestration of thoughts and actions and
thus has been referred to as the CEO of the brain. From
an evolutionary perspective, it has emerged relatively
recently and shows the greatest expansion at the gross
anatomy level. The PFC also shows an especially prolonged
period of postnatal maturation.1,2 Recent global transcrip-
tome analyses of the developing human PFC have shed
light on some of the key processes and genes that con-
tribute to the uniqueness of the human PFC and have
implicated involvement of epigenetic mechanisms.3–5
DNA methylation at CpG dinucleotides has long been
considered a key mechanism of transcriptional regulation
and a critical factor in embryonic development and in
cancer.6,7 However, little is known about the normal
developmental changes in DNA methylation of the
human PFC, particularly during early life. These early
epigenetic changes could be particularly relevant for
understanding the mechanisms of neurodevelopmental
brain disorders, such as autism (MIM 209850) and schizo-
phrenia (MIM 181500).8,9 Tissue-, sex- and age-specific
effects on DNA methylation in human samples have
been reported,10–17 but there are no reports of genome-
wide DNA methylation in the human brain across the life-
span. In this study, we investigated the genome-wide
temporal dynamics of DNA methylation in a large cohort
of well-characterized human PFC specimens from the
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wide SNP association analysis and examined relationships
with mRNA expression. We focus in this report on CpG
dinucleotides located primarily in the putative 50 promoter
regions of known genes. Although recent work has empha-
sized the importance of DNA methylation in gene regions
outside 50 domains,13 understanding how DNA methyla-
tion varies in promoter regions in normal brains across
the lifespan and how it is associated with genetic variance
is an important element in the interpretation of patholog-
ical changes in brain disorders and in understanding gene
expression and gene function.Subjects and Methods
Human Postmortem Brain Tissue Collection
Postmortem human brains from nonpsychiatric controls (108)
were collected at the Clinical Brain Disorders Branch (National
Institute of Mental Health) under protocol 90-M-0142 with
informed consent from the next-of-kin and at the Brain and Tissue
Bank for Developmental Disorders of the Eunice Kennedy Shriver
National Institute of Child Health and Human Development
(NICHD) under protocols NO1-HD-4-3368 and NO1-HD-4-3383.
Clinical characterization, neuropathological screening, toxicolog-
ical analyses, and dissections of the dorsolateral prefrontal cortex
were performed as previously described.18 Demographic data for
these samples are summarized in Table S1, available online.Genotyping Methods
SNP genotyping with HumanHap650Y_V3 or Human 1M-Duo_V3
BeadChips (Illumina, San Diego, CA) was carried out accordingational Institute of Mental Health, National Institutes of Health, Bethesda,
Medical Campus, Baltimore MD 21205, USA; 3Biomedical Research Center,
21224, USA; 4Department of Biostatistics, Johns Hopkins Bloomberg School
Genetics. All rights reserved.
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to the manufacturer’s instructions with DNA extracted from
cerebellar tissue. Genotype data were analyzed with the genotyp-
ing analysis module within the BeadStudio software (Illumina).
For data analysis, 605,371 SNPs with missing calls < 2%, Hardy-
Weinberg equilibrium p values R 0.001, and minor allele fre-
quenciesR 0.03 were used, from among a total of 654,333 shared
SNPs between the two types of chips.Methylation Methods
Genomic DNA was extracted from 100 mg of pulverized dorsolat-
eral prefrontal cortex (DLPFC) tissue with the phenol-chloroform
method. Bisulfite conversion of 600 ng genomic DNA was per-
formed with the EZ DNA methylation kit (Zymo Research). Meth-
ylation of DNA extracted from DLPFC was assessed according to
the manufacturer’s instructions with Infinium HumanMethyla-
tion27 BeadChips (Illumina). Quantitative measurements of
DNA methylation were determined for 27,578 CpG dinucleotides
spanning 14,495 genes. CpG sites were selected in CpG islands
(CpGIs) of the gene proximal promoter regions within 1 kb
upstream and 500 bases downstream from the transcription start
sites whenever possible, that is for 14,475 consensus coding
sequencing (CCDS) in the National Center for Biotechnology
Information database (genome build 36). Approximately 40% of
genes have no CpGIs in their promoter regions. On average, two
assays were selected per CCDS gene and from 3 to 20 CpG sites
for more than 200 cancer-related and imprinted genes. Among
27,578 total CpG sites, 20,007 are in CpGIs, 7,571 are in non-
CpGIs, and 1,086 are on the X chromosome. A CpGI is defined
as a nucleotide sequence of (1) 200 bp or greater in length; (2)
50% or greater in G-C percent and (3) 0.60 or greater in the ratio
of observed CpG sites over expected CpG sites. Methylation data
were analyzed with the methylation analysis module within
the BeadStudio software (Illumina). Methylation status of the
interrogated CpG sites was calculated as the ratio of signal from
amethylated probe relative to the sum of bothmethylated and un-
methylated probes. This value, known as b, ranges continuously
from 0 (completely unmethylated) to 1 (fully methylated). The
technical schemes of this array have been described in detail in a
previously published paper.19 To ensure data reproducibility, ten
samples were analyzed in duplicates starting from the bisulfite
conversion step, and high reproducibility was observed (r2 ranged
from 0.9973 to 0.9921). For validation, we used 92 samples from
the current study andmeasuredmethylation status at 34 CpG sites
by using an Illumina custom GoldenGate platform. The CpG site
positions for the probes were exactly the same as in the Infinium
arrays. The correlation between the data from the two platforms
was very high (r2 ¼ 0.79; Figure S1).
In this study, DNA was derived from tissue homogenates. We
cannot distinguish differential DNAmethylation within a popula-
tion of cells that are stable in their cell type from a change in the
abundance of cell types. It is most likely that both phenomena
contribute to signals measured in this study.Statistical Methods
We used surrogate variable analysis to account for known and
unknown factors, including batch effects.20 A step-wise analysis
was used for model selection for each CpG site. The influences
of age and sex on DNA methylation were examined by multiple
linear regression with age, sex, race, developmental life stage,
and age-by-stage interaction as the primary variables. Age was a
continuous predictor, whereas sex (male or female), race (individ-The Americauals of European descent or African Americans) and develop-
mental stage (fetal period, childhood [0–10 years], and postchild-
hood [ages older than 10 years]) were categorical predictors. The
use of age, stage, and age-by-stage interaction allowed the effects
of age on DNA methylation to be independent in each age stage
(i.e., to have different slopes between the stages) and thus enabled
fitting nonlinear trajectories over the entire lifespan into linear
models within the three life stages. In the age analysis, a false-
discovery-rate (FDR) correction was applied at the 0.05 level for
multiple testing.21 In the sex analysis, Bonferroni correction was
applied at the 0.05 level as in a previously published paper.14 In
order to eliminate the effects of age, sex, and race in the methyla-
tion quanatitative trait loci (mQTL) analysis, we used the residuals
from multiple regression (as described above) to analyze the asso-
ciations with SNP genotypes by utilizing an additive model
(multiple regression with allele dosage) in PLINK.22 We also used
multidimensional scaling (MDS) in PLINK across all genotypes
to identify population clusters and population outliers. Because
two races (individuals of European descent and African Ameri-
cans) showed two distinct clusters in the identity-by-state (IBS)
analysis, we also performed separate mQTL analyses in these
separate race groups. The methods were the same as those per-
formed in the combined cohort of individuals of European
descent and African Americans. SNPs within 1 Mb of a CpG site
were arbitrarily defined as cis-SNPs, and all the other SNPs were
defined as trans-SNPs, as in previous studies.11,23 A total number
of such cis-SNP associations were ~11 million, whereas a total
number of all possible associations were ~16 billion. In this
analysis, FDR was applied at the 0.05 level for multiple testing
corrections. We used the web tool DAVID functional annotation
to examine enrichment of gene ontology terms in the sets of
genes.24 We used weighted correlation network analysis
(WGCNA), an R package for weighted correlation network anal-
ysis,25 to describe the correlation patterns among CpG loci across
all the samples. For calculating correlations between expression
and DNA methylation levels, we used Pearson’s r.Results
Global Patterns of DNA Methylation
DNA methylation levels across all samples and CpG sites
showed a bimodal distribution with 63.3% of loci being
relatively hypomethylated (b < 0.2, where b is the ratio
of signal from a methylated probe relative to the sum of
both methylated and unmethylated probes) and 13% of
loci hypermethylated (b > 0.8; Figure S2). Among the
27,578 CpG sites surveyed on the array, 20,007 CpG sites
are in CpGIs and 7,571 CpG sites are in non-CpGIs.
Consistent with a previous study,19 the average DNAmeth-
ylation level (b value) across all samples was significantly
higher for the sites in non-CpGIs than for the CpGs in
CpGIs (0.62 5 0.26 and 0.14 5 0.23, respectively, p <
1015; Figure S3). Moreover, the distance of the methyla-
tion loci within CpGIs from transcription start sites (TSS)
predicted their level of methylation: the greater the
distance, the greater the proportion of hypermethylated
sites (Figure S4), consistent with a previous report.26 In
contrast, methylation status in non-CpGI sites was not
dependent on the distance from TSS. Finally, a relativelyn Journal of Human Genetics 90, 260–272, February 10, 2012 261
Figure 1. Depiction of Global DNA Methylation Patterns in Human Subjects across the Lifespan
(A) Histograms of subject ages in the brain collection. All fetal samples (left panel) are between 14 and 20 gestational weeks.
The following color scale is used: red, male fetal samples (n ¼ 14); orange, female fetal samples (n ¼ 16); light blue, male children
(n ¼ 10); green, female children (n ¼ 5); blue, males older than 10 years (n ¼ 32); and purple, females older than 10 years (n ¼ 31).
The same color scale is used in (B and C).
(B) Global DNA methylation pattern examined by multidimensional scaling for autosomal CpG sites. Each DNA methylation sample is
represented as a single point colored by the age of the subject. There is a tight cluster of the fetal samples, a progression of methylation
levels from the fetal period to childhood, and another cluster for postchildhood.
(C) Global DNAmethylation pattern of CpG sites on the X chromosome examined bymultidimensional scaling. Each DNAmethylation
sample is represented as a single point colored by the age of the subject and sex. Samples were distinctly segregated by sex. A progression
of methylation was also observed from the fetal period to postchildhood within each sex group.higher proportion of hypomethylated sites was observed
in larger CpGIs than in small CpGIs (<1,000 bp; Figure S5).
DNA Methylation Is Age Dependent
In order to visualize global patterns of DNA methylation
within the entire collection of samples, we used MDS27262 The American Journal of Human Genetics 90, 260–272, Februaryand showed that the overall pattern of genome-widemeth-
ylation is highly age dependent (Figure 1). For autosomal
loci, we observed a tight cluster of fetal samples, a progres-
sion of methylation levels in fetuses and children, and
another cluster of subjects older than 10 years, indicating
similarity of global methylation patterns within these age10, 2012
Figure 2. Depiction of Rates of DNA Methylation in Three Life Stages
(A) Rates of methylation change with age during three developmental life stages (the fetal period, childhood, and postchildhood/adult)
at each CpG site for 27,578 CpG loci. A rate of change is plotted on the x axis. The log10 p value is on the y axis, such that increasing
values indicate more significant changes in methylation with age within a given stage. Red dots represent significant age-related meth-
ylation changes at FDR < 0.05. The fastest rates of methylation changes occurred during the fetal period, involving predominantly
decreases inmethylation (negative values on the x axis). In contrast, during the childhood and adulthood the changes weremuch slower
and involved mainly increased methylation with aging (positive values on the x axis).
(B) Average rates of significant methylation changes with age within three developmental stages (red ¼ the fetal period, green ¼ child-
hood, blue¼ postchildhood). The absolute rate of the methylation change per year for the significant age-related CpG loci (FDR < 0.05)
is on the y axis. The fastest changes in methylation occurred during the prenatal period, followed by childhood and postchildhood. The
error bars represent standard deviations.
(C) Diagram showing the numbers of the CpG sites with significant age-related changes during the life stages. Of 27,578 CpG sites,
significant age-related changes in DNA methylation (FDR < 0.05) were observed at 865 sites during the fetal period, 5,506 sites during
childhood, and 10,578 sites during postchildhood. One hundred and thirty-eight sites out of the 252 sites that overlapped between the
fetal period and the childhood and 188 sites out of the 3,529 sites that overlapped between children and postchildhood showed the
opposite patterns of methylation (an increase followed by a decrease or vice versa) between these life stages. The transition from the fetal
life to childhood is frequently associated with a reversal of direction in DNA methylation profile.clusters and relative dissimilarity between the clusters
(Figure 1B). Also, the fetal group dramatically stands out
as the most dissimilar from all the other samples, reminis-
cent of our observations of the global prefrontal cortical
transcriptome in an expanded cohort of subjects.4 The
MDS analysis of methylation patterns for X chromosomal
loci showed that, as expected, the samples were distinctly
segregated by sex (Figure 1C).Within the sex groups, more-
over, we observed further clustering by age; again, fetal
samples formed separate clusters distinct from children
(0–10 years), whereas children’s methylation patterns
diverged from the older individuals. These results confirm
that both sex and age are important determinants of DNA
methylation at CpG sites on the X chromosome.
DNA Methylation Changes Rapidly during the Fetal
Period
In order for any investigator to conveniently explore DNA
methylation patterns as a function of age, sex, and other
demographic and genetic factors in our data, we have
created a user friendly web interface (BrainCloudMethyl;The Americasee Subjects and Methods for details). We found that
DNA methylation showed remarkable variation in the
DLPFC across human life, as indicated by the rate of
changes (Figure 2). By far, the fastest changes in DNA
methylation occurred during fetal period with methyla-
tion levels dropping or increasing by almost 80% per
year (with a 100% change reflecting complete demethyla-
tion or full methylation). During childhood and later in
life methylation changed at a much slower pace (23
orders of magnitude slower, Figure 2B), mimicking again
the DLPFC transcriptome data.4
Of the 27,578 CpG sites, significant age-related changes
in DNA methylation (FDR < 0.05) were observed at 865
sites during the fetal period (corresponding to 3.1% of all
sites; 2.1% decreased and 1% increased), 5,506 sites during
childhood (20%; 6.9% decreased and 13.1% increased),
and 10,578 sites during postchildhood (38.3%; 12.5%
decreased and 25.8% increased; Table S2). It is surprising
that the overall methylation changes during the fetal
period were much greater but involved fewer loci than in
other life stages, though this could reflect in part then Journal of Human Genetics 90, 260–272, February 10, 2012 263
limited age span of the fetal samples and/or greater vari-
ance in the fetal period.
Consistent with earlier reports,10,28 CpG sites in genes
involved in cancer and implicated in processes such as
tumor suppression, telomere maintenance, and DNA
repair, mostly increased methylation with aging. These
genes included MGMT (MIM 156569), ESR1 (MIM
133430), RASSF1 (MIM 605082), RAD50 (MIM 604040),
GSTP1/GTS3 (MIM 134660), RARB (MIM 180220),
MYOD1 (MIM 159970), LAMB1 (MIM 150240), and the
Werner gene WRN (MIM 604611), the latter gene associ-
ated with a premature aging syndrome (MIM 277700).
Interestingly, changes in age-related methylation of
many of these cancer-related genes started to occur during
childhood and continued into old age (e.g., PRDM1 [MIM
603423], LOX [MIM 153455], BAP1 [MIM 603089], APC
[MIM 611731], and TP53 [MIM 191170], known to be
tumor suppressors, as well as some oncogenes; Table S3).
Moreover, our data confirmed the ten top CpG sites with
increased methylation levels during aging of adult subjects
from a recent study of the brain.12
Transition from Fetal to Postnatal Age Is Associated
with Reversal of Direction in DNA Methylation
We found that 252 CpG sites showed correlations with age
during both the fetal period and childhood. Furthermore,
3,529 CpG sites were significantly correlated with age
during both childhood and postchildhood. Interestingly,
138 of 252 sites (54.8%) that overlapped between the fetal
period and childhood showed the opposite patterns
between these life stages (a shift from a decrease to an
increase of methylation with age or vice versa), whereas
only 188 sites of 3,529 (5.3%) that overlapped between
children and subjects older than 10 years demonstrated
this pattern (Figure 2C). This indicates that the transition
from fetal life to early childhood is associated with a
reversal of direction in DNA methylation change at
many loci, most often from demethylation prenatally to
increased methylation postnatally. This pattern is again
precisely the inverse of that which we have observed at
the transcriptional level, where there is a preponderance
of genes showing increases in expression with age in utero
followed by decreases postnatally.4 DAVID functional
annotation clustering analysis of the genes showing these
shifts revealed significant enrichment (2- to 4-fold, cor-
rected p < 0.05) for the terms ‘‘disulfide bond,’’ ‘‘glycopro-
teins,’’ and ‘‘signaling peptide,’’ characteristic of secreted
proteins involved in cell-cell signaling and interactions
with the extracellular matrix and known to play key roles
in morphogenesis, cellular differentiation, angiogenesis,
apoptosis, and modulation of the immune responses.
Figure 3A shows examples of different patterns of age-
related methylation.
Age-Related Changes in the Context of CpGI Location
To examine the effect of CpGI context on age-related
changes, we divided significant correlations with age on264 The American Journal of Human Genetics 90, 260–272, Februarythe basis of location within CpGI and non-CpGI, Figure 4.
We found that the effect sizes of age-related DNA methyl-
ation changes were larger at CpG sites in non-CpGIs than
in CpGIs in all three life stages. This is in agreement with
a rat study29 and the human adult brain study of Hernan-
dez et al.,12 which has also found that the effect sizes of
age-related effects were larger in non-CpGI sites, although
this study reported also more age-related associations in
CpGIs. The proportions of age-related changes in non-
CpGIs and CpGIs were 5.6% and 2.2% during the fetal
period, 28.1% and 16.9% during childhood, 47.6% and
34.9% during postchildhood (Fisher’s exact test p ¼
4.1 3 1042, p ¼ 3.4 3 1091, and p ¼ 7.9 3 1083, respec-
tively). Moreover, those CpG sites in CpGIs that did show
age-dependent changes were more likely to become more
methylated with age than the sites in non-CpGIs, which
were generally demethylated with aging, similar to the
report of Christensen et al.10 The ratios between increased
and decreased methylation at CpG sites in CpGIs versus
non-CpGIs were, respectively, 2.4 and 1.3 during child-
hood, and 2.7 and 1.2 during postchildhood (two-propor-
tion Z scores ¼ 10 and 11, respectively, p < 1015).
DNA Methylation Is Sex Biased
A majority of loci (85.8%) on the X chromosome showed
a sexually dimorphic pattern of DNA methylation (of
932 CpG sites significantly different between the sexes,
678 showed higher methylation in females and 254
showed higher methylation in males), whereas only 5%
of autosomal loci were significantly associated with sex
(of 1,333 CpG sites, 986 showed higher methylation in
females and 347 showed higher methylation in males,
5% Bonferroni correction, p < 1.8 3 106; Table S4). In
agreement with a previous report in human blood,30 meth-
ylation of X chromosome CpG sites showed markedly
larger sex differences than autosomal CpG sites, as indi-
cated by the average absolute values of beta regression
coefficients (0.21 and 0.015, respectively). Table 1 lists
top autosomal genes that showed sex differences. Exam-
ples of sex-biased genes include MAOA (MIM 309850) on
X chromosome and TLE1 (MIM 600189) on chromosome
9, a mammalian transcriptional corepressor participating
in neuronal differentiation as a negative regulator in the
central nervous system31 (Figure 3B). This gene is also asso-
ciated with hypermethylation and gene silencing in hema-
tologic malignancies.32
Comethylation Networks
To gain insight into the relationships among all 27,578
loci, we conducted WGCNA.25 The WGCNA is used here
to find clusters (modules/groups) of highly correlated
CpG sites, to relate modules to each other and to external
sample traits (such as age and sex). Modules were created
on the basis of high absolute correlations (i.e., they formed
an unsigned comethylation network). Using the absolute
values of the correlation coefficients between the profiles
of CpG loci, we detected five modules, corresponding to10, 2012
Figure 3. Depiction of Individual Loci’s DNA Methylation Signatures across the Human Lifespan
(A) Depiction of individual loci’s DNAmethylation signatures across the human lifespan, illustrating three patterns of DNAmethylation
across the fetal, child and adult life periods. Methylation levels are on the y axis, with age on the x axis. The CpG site of CDH22
(cg04640913) showed significant age-related increases during the fetal period, childhood, and postchildhood (p ¼ 2 3 106, p ¼ 1 3
103, and p¼ 2.33 104, respectively). The CpG site of SCGB3A2 (cg19530885) showed significant age-related decreases during the fetal
period, childhood, and postchildhood (p ¼ 4.5 3 1013, p ¼ 9.5 3 103, and p ¼ 2.4 3 104, respectively).The CpG site of NOS1
(cg21006686) showed a significant age-related decrease during the fetal period (p ¼ 8.6 3 104) and increases during childhood
and postchildhood (p ¼ 2 3 108 and p ¼ 1.1 3 102, respectively).
(B) Depiction of individual loci’s DNAmethylation signatures across the human lifespan, illustrating sex differences. Females are red and
males are blue. The CpG sites ofMAOA (cg19441691) and TLE1 (cg15915418) showed significant sex differences (p ¼ 1.04 3 1062 and
1.27 3 1065, respectively).the blocks of highly interconnected loci, which contained
10,422; 5,989; 825, 361, and 288 CpG loci in modules 1–5,
respectively, Figure 5A. The remaining loci (n ¼ 9,693) did
not intercorrelate and thus were not included in the clus-
ters. Module 3 clustered sex-biased CpG loci. Loci clustered
in modules 2, 4, and 5 were highly correlated with age and
showed module-specific patterns of age-related methyla-
tion (Figure S6). This is also clearly seen in the heat map
of DNA methylation across all five modules (Figure 5B).
To determine whether comethylation modules were bio-
logically meaningful, we used functional enrichment and
gene ontology analysis. DAVID functional annotation
clustering revealed significant ~2-fold enrichment of genes
related to glycoproteins, glycosylation, disulfide bonds,
and signaling in modules 2, 4, and 5 (Benjamini corrected
p values ¼ 3106 to 31030). Interestingly, the most
numerous module 1 contained CpG sites, principally
located in the CpGIs (92%), which were almost completely
unmethylated (average methylation b ¼ 0.033), and by
and large showed no age dependence across the life span,
suggesting that this module might represent sites involved
in permissive transcription.The AmericaDNA Methylation Correlates with Expression of
a Subset of Genes
Genome-wide transcriptional profiling was performed in
the DLPFC in the same subjects with custom-spotted two-
color microarrays.4 Expression data are available at the
Gene Expression Omnibus (GEO) database. To interrogate
relationships betweenDNAmethylation and transcription,
we correlated (Pearson’s correlation) methylation status at
CpG loci in gene promoters with expression of all probes
on the array corresponding to the same gene (a total
number of such correlations was 45,499 for 12,277 genes).
Overall, across all CpG sites, there was poor correlation
with expression as indicated by the preponderance of
values near zero in the distribution of correlation coeffi-
cients across all comparisons, Figure 6A. Moreover, the
distribution of correlation coefficients was almost com-
pletely symmetrical, indicating that methylation might
suppress aswell as activate transcription of a subset of genes
that showed concordant changes in methylation and
expression (3,363 significant correlations after Bonferroni
correction, p < 3106, of which 1,774 [52.7%] were nega-
tive; Table S5). Importantly, CpGI context appeared ton Journal of Human Genetics 90, 260–272, February 10, 2012 265
Figure 4. Depiction of Age-Related Changes in DNA Methylation in Three Life Stages as a Function of CpGI Context
Black lines show density distributions of regression coefficients for age term for the CpG loci located in the CpGIs. Red lines show density
distribution of regression coefficients for age term for the CpG loci located outside the CpGIs. More loci are demethylated than hyper-
methylated during the fetal period, whereas increasedmethylation with age dominates in postnatal life (childhood and postchildhood).
The effect sizes are larger for loci outside the CpGIs than those located in the CpGIs.
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Table 1. Top Ten Autosomal Genes with Most Significant Sex
Differences
CpG Locus Chromosome
Gene
Symbol
p Value
(log) Difference
cg15915418 9 TLE1 64.9 female > male
cg07711515 9 BAG1 60.8 female < male
cg27063525 6 C6orf68 46.7 female > male
cg11673803 10 GLUD1 44.3 female > male
cg21243096 1 POUF3F1 44.2 female > male
cg04455759 11 SDHD 28.4 female < male
cg08284151 12 DPPA3 20.1 female > male
cg05924191 15 FLI20582 17.8 female > male
cg23758485 16 SMPD3 17.4 female > male
cg07494248 2 HSPD1 16.4 female > male
Figure 5. Depiction of Hierarchical Clustering with the
Weighted Correlation Network Analysis
(A) Hierarchical clustering dendrogram obtained with the
weighted correlation network analysis. The first color row under-
neath (labeled Group) shows the module assignment determined
by the Dynamic Tree Cut. The second color row (labeled chrX)
represents autosomal (gray) or X chromosomal (red) location of
the loci in the module. The third row (labeled CpGI) shows
whether the loci are located in the CpGIs (red) or outside the
CpGIs (gray).
(B) Heat map visualization of DNA methylation status of six
modules. A hierarchical clustering was conducted across 108
subjects shown in rows (a vertical color bar on the left indicates
sex: red ¼ females, blue ¼ males; a vertical color bar on the right
of the picture indicates age groups: red¼ fetal, green¼ childhood,
blue¼ postchildhood) and sixmodules in columns (CpG loci were
clustered into comethylation modules: groups 0–5, with group
0 containing unclassified loci). Color key on top indicates DNA
methylation values: lowest, pink highest, blue lowest.play a role in predicting gene expression as there was an
over 2-fold higher proportion of significant correlations
involving sites outsideCpGI thanof significant correlations
involving those sites in CpGIs (out of all correlations with
loci outside CpGIs 12.6% were significant at p < 3106,
whereas only 5.7%of loci inCpGIs were significantly corre-
lated). Of particular interest is NNAT (neuronatin [MIM
603106]), an imprinted gene on chromosome 20, with the
second highest negative correlation between DNAmethyl-
ation and expression (r¼0.922, p¼ 1.33 1045). NNAT is
expressed only from the paternal allele, is involved in the
regulation of ion channels during early brain development,
and has been implicated in pituitary cancers by means of
loss of expression due to hypermethylation at the promoter
CpG sites.33 Our data suggest that promoter DNAmethyla-
tionofNNATmight alsobe important in the transcriptional
regulation of NNAT during normal PFC development
because its expression falls dramatically during the transi-
tion from the fetal period to infancy and slowly thereafter,
whereas DNA methylation follows exactly the opposite
pattern (Figure 6B).
Remarkably, transcription of a group of methyltrans-
ferases of the DNMT3 family, carrying out dramatic reprog-
ramming of DNA methylation during early embryonic
development, appears to be, at least in part, also regulated
by DNAmethylation. Methylation levels at the CpG loci in
the promoters of DNMT3A (MIM 602769) and DNMT3B
(MIM 602900) as well as DNMT3L (MIM 606588), which
lacks the catalytic domain but binds to DNMT3A and
DNMT3B variants and facilitates their chromatin targeting,
are significantly and inversely correlated with the expres-
sion of these genes (r values from 0.66 to 0.46, p values
from 5.8 3 1015 to 3.8 3 107). Consistent with their
essential role in the establishment of early DNA methyla-
tion patterns, expression levels of DNMT3A, DNMT3B,
and DNMT3L variants are high during the fetal period
and drop by an approximately 2- to 4-fold decrease by
birth, whereas methylation follows the opposite trajectoryThe America(Figure S7). Our data suggest that genes controlling de
novo DNA methylation are themselves subjected to epige-
netic regulation and that this process continues well into
childhood years.
Methylation Quantitative Trait Loci (mQTL) Analysis
To identify population clusters and potential population
outliers, we used IBS analysis across all genotypes and
subjects and found that the two races (individuals of Euro-
pean descent and African Americans) formed clearly
distinct clusters (Figure S8). We identified one outlier
among individuals of European descent, who was deleted
from mQTL analysis. We conducted genome-wide associa-
tion analysis of SNPs with DNA methylation and found
a large number of significant mQTLs. Because mQTL anal-
ysis was performed with residuals frommultiple regression
with sex, age, stage, age-by-stage interaction, and race,n Journal of Human Genetics 90, 260–272, February 10, 2012 267
Figure 6. Depiction of Correlations between DNA Methylation
and Gene Expression
(A) Histogram of correlation coefficients for Pearson’s correlations
between DNAmethylation and gene expression. Green line shows
correlations of expression with methylation at the loci located in
CpGIs, red line, with loci outside CpGIs.
(B) An example of opposite patterns of DNA methylation (left)
and expression (right) changes with age (x axis) for NNAT
(neuronatin).these effects would not be expected to affect the SNP
association results. Quantile-quantile (Q-Q) plots clearly
demonstrate the abundance of extreme association effectsTable 2. Top Ten Most Significant cis mQTLs
CpG Locus CpG Gene Symbol SNP Symbol S
cg17749961 LCLAT1 rs1662955 L
cg17749961 LCLAT1 rs1723167 L
cg19766460 C21orf128 rs1571737 U
cg17749961 LCLAT1 rs1612616 L
cg01889448 HLA-DQB1 rs1063355 H
cg12339802 C1orf109 rs11264091 E
cg06665322 GPA33 rs2281962 G
cg14129786 MGMT rs7076950 M
cg06509940 CD80 rs4330287 A
cg08679985 KLF17 rs663818 K
268 The American Journal of Human Genetics 90, 260–272, Februaryover that expected by chance in all subjects as well as sepa-
rately in each race cohort (Figures S9A and S9B). In the
cis-analysis (cis defined as within 1 Mb of the CpG site),
2,836 SNP genotype-CpG pairs were significantly corre-
lated (FDR < 0.05; Table S6; for top associations see
Table 2). HLA-DQB1 (MIM 604305), with mQTL p value
1029 (Figure 7A), is a highly polymorphic gene coding
a major histocompatibility complex class II protein, which
has been implicated in a host of autoimmune diseases,
including insulin-dependent diabetes mellitus (MIM
222100), gliomas, multiple sclerosis (MIM 126200), schizo-
phrenia, and other disorders.34,35
Plotting p values against the distance of SNPs from the
CpG sites showed that the strongest associations were
with the SNPs located relatively close to CpG sites, but
the association signal extended at least up to 300 kb and
in some cases as far as 1 Mb from the gene (Figure 7B).
The average distance between significantly associated
cis-SNPs and CpG sites was 86.2 kb. One hundred and
sixty-five SNPs were associated with two or more different
CpG sites. We found 401 trans-mQTLs (FDR < 0.05; Table
S7). Table 3 lists the top ten trans-SNP-CpG association
pairs with the most significant p values. To address the
possibility that the highly significant association data
were driven by population stratification, the association
analysis was also performed in samples from African Amer-
ican and individuals of European descent separately. The
top 200 African American cis-associations and 91.5% of
the top 200 individuals of European descent cis-associa-
tions were also found to be significant in the analysis of
all subjects (FDR < 0.05; Tables S8A and S8B). Finally, it
should be noted again that the reported significant associ-
ations are, by design, not age (or stage) dependent because
age and developmental stage were used to generate resid-
uals for mQTLs. This is further illustrated in the examples
of the genotypic groups at highly associated SNPs,
showing consistently different methylation across the life-
span (Figure S10). Overall, our results revealed that DNA
methylation is associated with genetic variance in
numerous CpG sites, and cis-SNP associations are moreNP Gene Symbol Chromosome p Value (log)
CLAT1 2 39.9
CLAT1 2 36.4
MODL1 21 36.1
CLAT1 2 35.8
LA-DQB1 6 29.4
PHA10 1 28.7
PA33 1 28.3
GMT 10 27.0
DPRH 3 26.9
LF17 1 26.8
10, 2012
Figure 7. Depiction of Associations between the Genotype and
DNA Methylation
(A) Depiction of the mQTL for the CpG site cg01889448 and
rs1063355 in HLA-DQB1 (p ¼ 1029). Three genotypes of
rs1063355 are 1/1 in red (n ¼ 21), 1/2 in green (n ¼ 57), and 2/2
in blue (n ¼ 30). The lines in the bar graph indicate the median,
and the bars (whiskers) represent the minimum and maximum
of the data after the removal of the outliers.
(B) The relationship between the strength of association and the
distance of the SNP from the CpG site. Only significant cis-SNPs
associations are plotted (FDR < 0.05). The distance of SNPs from
the CpG sites in base pairs is on the x axis and the log10 p values
of SNP association with DNA methylation. Plotting p values
against the distance of SNPs from each CpG site showed that the
highest associations were with the SNPs located close to CpG site.
Table 3. Top Ten Most Significant trans mQTLs
CpG Locus
CpG Gene
Symbol
SNP
Symbol
SNP Gene
Symbol
p Value
(log)
cg18984499 RPL26 rs11847580 C14orf72 24.1
cg17704839 UBL5 rs733675 RHOT1 23.5
cg18634211 LIN28 rs2288322 FKBP7 21.5
cg18634211 LIN28 rs10207436 PRKRA 21.4
cg25299176 YWHAE rs4281963 LOC647002 19.7
cg03923277 TDG rs326387 TMEM132B 19.5
cg25299176 YWHAE rs6716175 LOC440917 18.8
cg18984499 RPL26 rs4906142 PPP2R5C 18.5
cg13514129 MACF1 rs12130070 SMYD3 18.4
cg13514129 MACF1 rs2878079 SMYD3 18.4frequent and more pronounced than trans-SNP associa-
tions. Further exploration of methylation profiles for
individual genes across the lifespan and the genetic associ-
ations of those genes is made possible by an easily acces-
sible stand-alone application, BrainCloudMethyl. This
will enable additional discovery that might have profound
consequences for our understanding of molecular mecha-
nisms by which risk-associated SNPs exert their patholog-
ical effects in brain disorders.Discussion
We report a genome-wide study of age-related DNA meth-
ylation, focused on 50 promoter regions of genes, in the
developing human DLPFC, including the prenatal period.The AmericaThe fastest changes in methylation occurred during the
prenatal period, and the transition from fetal life to early
childhood was associated with a reversal of direction of
DNA methylation, typically from demethylation to in-
creased methylation. As demonstrated before, variations
in methylation during aging exist even between monozy-
gotic twins, that is independently of the genetic
sequence,36,37 and are associated with phenotypic discor-
dances between the twins, including disease traits.38–40
Although the causes of age-related methylation changes
remain to be determined, increases in methylation with
age are thought to reflect the accumulation of stochastic
methylation events over time (epigenetic drift), whereas
decreases might be related to altered fidelity of DNA meth-
yltransferases.41 This suggests that epigenetic factors might
play an important role in the pathogenesis of diseases and
implies that examining epigenetic mechanisms associated
with aging and contributing to the accumulation of
methylation errors might be essential to understand
pathogenesis of age-related brain disorders.
Consistent with the findings in tissue differentiation
and cancer,13 we found that age-related DNA methylation
changes were more likely to occur outside the so-called
CpGIs than in CpGIs. This trend could be explained by
specific protection mechanisms of CpGIs from de novo
methylation.42,43 Moreover, those CpG sites in CpGIs
that showed age-dependent changes were more likely to
gain rather than loose DNA methylation with aging in
accordance with Christensen et al.10 and Hernandez
et al.12 who interrogated cancer-related autosomal loci in
human tissues and in adult human brains, respectively.
Our results of differential age-related patterns between
CpGIs and non-CpGIs across more than 27,000 loci
primarily in 50 promoter regions suggest that global meth-
ylation changes within these regions can be affected by
promoter CpG density during development. A recent
paper reporting that most tissue-specific DNAmethylation
occurs not in CpGIs but in CpGI shores, which are located
within 2 kb of islands,13 might support this notion.n Journal of Human Genetics 90, 260–272, February 10, 2012 269
Neurodevelopmental behavioral disorders, such as
autism and schizophrenia, are thought to have their
origins in utero or around birth, although the main symp-
toms emerge later in life, typically around adolescence/
young adulthood in the case of schizophrenia.44 Our
results showing remarkable DNA methylation changes,
especially in early life stages, suggest that altered methyla-
tion during these periods might be critical for the patho-
genesis of developmental brain disorders. Consistently,
we found dynamic age-related methylation changes across
the life span, and particularly in the transition from fetal to
postnatal life stage, for genes, such asDLG4 (MIM 602887),
DRD2 (MIM 126450), NOS1 (MIM 163731), NRXN1 (MIM
600565), and SOX10 (MIM 602229), that have been
implicated in schizophrenia and autism (Figure S11).
DNMT1 (MIM 126375), a maintenance DNA methyltrans-
ferase, is overexpressed in the cerebral cortex of patients
with schizophrenia and bipolar disorder (MIM 125480).45
It is possible that aberrant DNA methylation in schizo-
phrenia might be a consequence of altered normal devel-
opmental trajectories triggered either by dysregulation of
methyltransferase activity and/or the involvement of
environmental genetic factors affecting DNA methylation
status. DNA methyltransferases participating in de novo
methylation also might be involved (e.g., DNMT3A,
DNMT3B, and DNMT3L). DNMT3A, shown to form com-
plexes and work in concert with DNMT3B and DNMT3L,
can specifically regulate expression of neurogenic genes
and affect synaptic plasticity, learning, and memory in
forebrain excitatory neurons.46–48 Consistent with this
notion, the subset of our transcriptome data, which corre-
late inversely with DNAmethylation levels, show dramatic
age-related changes in the DLPFC across the lifespan,
particularly during the transition from the fetal to the
postnatal period, suggesting dynamic regulation of ex-
pression of these genes by DNA methylation during
development.
This genome-wide study also identifies sex-biased auto-
somal genes in DNAmethylation in normal humanDLPFC
and thus might be useful to evaluate sex differences in
various brain disorders. Interestingly, five of the ten most
significant associations with sex among autosomal genes
(C6orf68/NUS1 [MIM 610463], DPPA3 [MIM 608408],
FLJ20852, TLE1, and GLUD1 [MIM 138130], which
encodes an enzyme central to glutamate metabolism and
implicated in schizophrenia and cognition49,50) were also
identified in a previous study that used saliva,14 suggesting
that at least some epigenetic differences between sexes are
not tissue specific.
Our data also revealed, consistent with previous
reports11,23 that DNA methylation at numerous CpG sites
is associated with genetic variance. Not surprisingly, we
found that cis-SNP associations are more frequent and
more pronounced than trans-SNP associations. Six of our
ten most significant cis-SNP-CpG association pairs and
eight of our tenmost significant trans-SNP-CpG association
pairs were reported by Gibbs et al.11 Our findings of SNP270 The American Journal of Human Genetics 90, 260–272, Februaryassociations with DNA methylation are consistent with
the possibility that some SNPs associated with increased
risk for neuropsychiatric diseases might affect gene expres-
sion through DNA methylation, in addition to their direct
effects on mRNA expression.51 Finally, despite similarities
in the global patterns of transcription and DNA methyla-
tion in the DLPFC over the human lifespan, we found a
relatively limited number of intercorrelated CpG site-
expression probe pairs. This confirms earlier evidence that
transcription is only partially regulated by promoter DNA
methylation at the CpG sites examined in the study and/or
that the limited coverage of transcripts (especially of alter-
native splice variants that might be differentially regulated
by methylation) and of CpG sites (in particular those
outside the CpGIs) precludes fully capturing these relation-
ships. Another limitation is our inability to distinguish
between methylation and 5-hydroxymethylation of cyto-
sine (5hmC) that appears to be abundant in brain and has
recently been discovered to play a critical role in dynamic
regulation of genes silenced by methylation.52 Finally, it is
also possible that recent advances in the knowledge about
gene structure will require re-evaluation of the putative
promoter regions. Further studies will be needed to reveal
how genetic and epigenetic variation, together and inde-
pendently of each other, are involved in the pathophysi-
ology of neuropsychiatric diseases.Supplemental Data
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